|
|
Biomerge Industries Limited. - Comparative Business Analysis Snapshot
Business Description
Biomerge Industries Limited. Formerly known as Xillix Technologies Corp.. The Group's principal activity is to research, develop and commercialize medical imaging technologies for detection and localization of cancer. The Group's technology is based on a concept called LIFE, which means Light Induced Fluorescence Endoscopy. This technology provides the physicians with tools for detecting pre-cancerous and cancerous cells. It also helps the physicians to treat cancer disease. The operations of the Group are carried out in Canada, the United States and Asia.
Competitor Analysis
This analysis compares Biomerge Industries Limited. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
